Medical/Pharmaceuticals
Medtronic Malaysia and Malaysian Society of Colorectal Surgeons sign MOU to enhance medical training and education programs
KUALA LUMPUR, Malaysia, Feb. 25, 2025 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, announced that Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorandum of Understanding (MoU) to jointly organize surgical workshops aimed at ...
2025-02-25 10:00
2323
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S.
Another Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines inChina is in full swing. On February 23, PRC vaccine leader AIM Vaccine (06660.HK) announce...
2025-02-25 08:00
2123
3Z Pharmaceuticals Publishes Breakthrough Study on Shared Metabolic Pathways in ADHD Therapeutics
REYKJAVIK, Iceland, Feb. 24, 2025 /PRNewswire/ -- 3Z Pharmaceuticals, a CNS-focused therapeutic development specialist, today announced the publication of agroundbreaking study in The Journal of Pharmacology and Experimental Therapeutics, unveiling novel insights into the metabolic mechanisms of...
2025-02-24 23:35
1802
LabConnect and Australian Clinical Labs' Specialised Trials Announce Strategic Partnership in Australia and Asia Pacific Region
PORT MELBOURNE, Australia and JOHNSON CITY, Tenn., Feb. 24, 2025 /PRNewswire/ -- LabConnect and Australian Clinical Labs' (ACL) Specialised Trials have forged a strategic partnership to expand support of clinical trials inAustralia and the Asia-Pacific region. This exclusive, multi-year agreement...
2025-02-24 22:06
2440
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI
* Major finding provides mechanistic explanation for ibezapolstat's (IBZ) selectivity in that the predicted bactericidal interaction between IBZ and its target DNA pol IIIC is conserved across most of the Bacillota phylum, including C. difficile, while certain beneficial taxa are naturally resi...
2025-02-24 21:00
1965
Vantage Foundation Brings Hope and Support to Patients at National Burn Hospital, Hanoi
HANOI, Vietnam, Feb. 24, 2025 /PRNewswire/ -- Vantage Foundation proudly announces its partnership with National Burn Hospital Le Huu Trac inHanoi, a leading medical facility specialising in burn treatments & rehabilitation to provide support and financial assistance to patients of all ages under...
2025-02-24 17:05
2906
AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside
HONG KONG, Feb. 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onFebruary 23, 2025, announced that the company is fully deploying the DeepSeek large model and promoting the application of DeepSeek R1 version across all business ...
2025-02-24 11:20
2573
NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer
SAN FRANCISCO and SUZHOU, China, Feb. 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2025-02-24 07:56
2980
Corti Collaborates with Wolters Kluwer to Bring UpToDate's Trusted Clinical Content to its Specialized AI Platform
Clinicians can now access evidence-based clinical content live during consultations via the Corti Assistant app NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Corti, the leading AI and research company in healthcare, today announced it is collaborating withWolters Kluwer Health to integrate its market-...
2025-02-20 22:00
2289
Syensqo and Emulseo announce strategic partnership for advanced applications in the healthcare sector
Exploring new opportunities within the fast-growing market of microfluidics BORDEAUX, France, Feb. 20, 2025 /PRNewswire/ -- Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in formulations for microfluidic te...
2025-02-20 21:00
2370
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended31 December 2024. All figures are in AU$ unless stated otherwise. FY2024 highlights * ...
2025-02-20 20:23
3692
Check PD: New Parkinson's Screening App with 90% Accuracy--Download Now!
BANGKOK, Feb. 20, 2025 /PRNewswire/ -- King Chulalongkorn Memorial Hospital
2025-02-20 10:00
2409
BluMaiden Biosciences Appoints New US-based Leadership to Accelerate Global Expansion
- Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named Chair of the Scientific Advisory Board, joins Board of Directors - Appointment of US-based CEO completes the recent build out of BluMaiden's executive team in preparation for commercialization, supported by COO Dr....
2025-02-19 20:00
2489
Ascletis Announces Positive Interim Results from First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30
- ASC30 oral once-daily tablet demonstrated a 6.3% mean body weight reduction from baseline after 28-day treatment in multiple ascending dose (MAD)cohort 2 (weekly titrations of 2 mg, 10 mg, 20 mg, and 40 mg). - ASC30 oral once-daily tablet also demonstrated a 4.3% mean body weight reduction fr...
2025-02-19 20:00
3164
Hong Kong to Host Landmark International Symposium on Genomic Medicine
HKGI Partners with Global Leaders to Chart a Course for Healthcare Transformation HONG KONG, Feb. 19, 2025 /PRNewswire/ -- Genomic medicine has been gaining global prominence for its vast potential to revolutionise healthcare services. In the case of rare conditions, genomic medicine has been pa...
2025-02-19 11:43
2923
SingHealth and Philips sign MOU to advance digital-first healthcare to future-proof care delivery
* New partnership set to accelerate digital healthcare transformation in Singapore, with a focus on co-designing and integrating Artificial Intelligence (AI) and predictive data management to improve patient care by 2028 * Projects under this partnership aim to: o Streamline imaging data wor...
2025-02-19 10:13
2887
Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches
ZUG, Switzerland, Feb. 18, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a late stage MedTech start up, has developed a breakthrough method and a product for the therapy of heart failure. The product - an electronic device called C-MIC - has already successfully been tested in patients in a pilot...
2025-02-18 23:20
2635
CMI Media Group unveils inaugural Media Vitals HCP Global research
LONDON, Feb. 18, 2025 /PRNewswire/ -- Healthcare agency CMI Media Group, a WPP company (NYSE: WPP), has unveiled its first ever Media Vitals(TM) HCP Global research. The new report provides insights into the media preferences of healthcare professionals (HCPs) on a global scale. Insights were ga...
2025-02-18 21:25
1943
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent to U.S. and European reference Apixaban tablets (Eliquis®) ...
2025-02-17 21:03
2906
3Z Pharmaceuticals Unveils Landmark Study Supporting Calcium Channel Blocker as a Groundbreaking ADHD Therapy
REYKJAVIK, Iceland, Feb. 17, 2025 /PRNewswire/ -- 3Z Pharmaceuticals today announced the publication of a transformative study in Neuropsychopharmacology, highlighting compelling scientific evidence that positions the mechanisms engaged by amlodipine, an L-type calcium channel blocker (LTCC), as...
2025-02-17 19:25
2149
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 320 media titles]
2026-02-16 10:00
Ascentium Acquires Clara, Expanding into the Abu Dhabi Global Market (ADGM) and Strengthening its Middle East Presence
[Picked up by 310 media titles]
2026-02-12 14:00
Carro unveils quirky generative AI ad campaign highlighting its 'Surprisingly Short' AI-enabled car-selling process
[Picked up by 296 media titles]
2026-02-11 11:00
Vizzio Technologies Strengthens Leadership As Global Growth Accelerates
[Picked up by 294 media titles]
2026-02-11 14:59
Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 270 media titles]
2026-02-17 19:12
Most Read
Datasea Reports Second Fiscal Quarter 2026 Results
2026-02-12 22:20
6977
eufy Raises the Bar for Home Cleaning with Omni C28, Delivering One-Pass-Clean Performance with HydroJet™ Self-Clean Roller Mop
2026-02-14 10:00
6737
NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell
2026-02-12 21:56
6034
